510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K221801Substantially Equivalent

ADVIA Centaur® Anti-Müllerian Hormone (AMH)

Siemens Healthcare Diagnostics Inc., Tarrytown NY / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)510(k) summary (opens on fda.gov)

K221801 is the FDA 510(k) clearance record for ADVIA Centaur® Anti-Müllerian Hormone (AMH), a class II device, cleared for Siemens Healthcare Diagnostics, Inc. on under FDA product code PQO (Anti-Müllerian Hormone Test System). FDA's definition for product code PQO reads: "An Anti-Müllerian hormone test system is an in vitro diagnostic device intended to measure anti-Müllerian hormone in human serum and plasma. The test is intended to be used as an aid for assessing ovarian reserve in women". FDA records list 1,204 510(k) clearances for Siemens Healthcare Diagnostics, Inc., from to . As of , FDA records show no recalls naming K221801.

Clearance record

Decision date
Received
(346 days to decision)
Product code
PQO Anti-Müllerian Hormone Test System
Regulation
21 CFR 862.1092
Device class
Class II
Review panel
Clinical Chemistry
Applicant
Siemens Healthcare Diagnostics, Inc. 511 Benedict Ave., Tarrytown NY
510(k) summary
Summary PDF
Third party review
No

Clearances, product code PQO

Trailing 12 months

FDA records hold no clearances under product code PQO in the trailing twelve months.

FDA records show no clearances under product code PQO in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code PQO, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260